Skip to content

24/7 dementia helpline 800-272-3900

Dementia Today

Finding the silent killer - a biomarker test for atherosclerosis

Dementia TodayPublished January 13, 20123 min read

Key points

  • Furring of the arteries, atherosclerosis, is a leading cause of death across the world.
  • Dr Feng Cheng and the team were able to reduce this initial set to 56 genes by focusing on genes directly involved in inflammation, lipid, carbohydrate and protein metabolism, and genes known to be responsible for the maintenance of blood cells.
  • If you are writing for the web, please link to the article.
  • BMC Medical Genomics is an open access, peer-reviewed journal that considers articles on all aspects of functional genomics, genome structure, genome-scale population genetics, epigenomics, proteomics, systems analysis, and pharmacogenomics in relation to human health and disease.

Furring of the arteries, atherosclerosis, is a leading cause of death across the world. Atherosclerosis leads to peripheral arterial disease, coronary heart disease, stroke and heart attacks. However, atherosclerosis is a sneaky killer – most people do not realize they have it until they have cardiovascular disease (CV). New research published in BioMed Central’s open access journal BMC Medical Genomics has identified a set of biomarkers which can be used to test for early stage atherosclerosis.

Researchers from the University of Virginia compared biomarkers isolated from monocytes (a type of white blood cells) in blood of patients with a family history of high cholesterol levels (familial hypercholesterolemia) to healthy controls. 363 genes were found to be differentially regulated (turned up or down) between the two groups. Familial hypercholesterolemia is a well-known genetic disease caused by a mutation in the LDL receptor which causes early onset atherosclerosis. People with two copies of the mutated LDL receptor (homozygous) have an even higher risk of atherosclerosis than those with one mutated and one normal copy (heterozygous).

Dr Feng Cheng and the team were able to reduce this initial set to 56 genes by focusing on genes directly involved in inflammation, lipid, carbohydrate and protein metabolism, and genes known to be responsible for the maintenance of blood cells. Genome-wide expression profiling, gene functional inference and multivariate statistical techniques were further used to ‘fine tune’ the test. This ‘prediction array’ was able to spot the people with high cholesterol, separating the patients with familial hypercholesterolemia from the control group.

Dr Jae Lee, who led the study, explained “By splitting our 56 genes into three sets, and using the COXEN algorithm, which was originally developed to identify genes involved in cancer with potentially diagnostic or therapeutic properties, we found that we could further refine our test and separate out the very high risk group.” Dr Ellen Keeley continued, “This biomarker test, which only requires a blood sample, could be further developed to predict the risk of silent atherosclerosis in clinical practice.”

###

Notes to Editors

1. Molecular prediction for atherogenic risks across different cell types of leukocytes
Feng Cheng, Ellen C Keeley and Jae K Lee
BMC Medical Genomics (in press)

Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central’s open access policy.

Article citation and URL available on request at press@biomedcentral.com on the day of publication.

2. BMC Medical Genomics is an open access, peer-reviewed journal that considers articles on all aspects of functional genomics, genome structure, genome-scale population genetics, epigenomics, proteomics, systems analysis, and pharmacogenomics in relation to human health and disease.

3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.

###

Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-203-192-2370
BioMed Central

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If a person with dementia is missing, injured or in danger, call 911 or your local emergency number.

Filed underDementia News

Worried about memory changes?

Normal aging, or an early warning sign?

Ten common changes, each set beside what is typical with age. Tick what you have noticed and see what to do next.

Open the 10-sign checklist

Getting help

Sudden changes are not just the dementia.

Dementia usually changes slowly. A sharp change over hours or days can mean an infection, delirium, a stroke or a medication problem, and needs a doctor the same day. Call 911 or your local emergency number if you see any of these:

  • Confusion that comes on suddenly, over hours or days
  • Face drooping, arm weakness or slurred speech
  • A fall, a head injury or new severe pain
  • Very drowsy or hard to wake

The free Alzheimer’s Association Helpline answers questions about memory loss, diagnosis and caregiving, day and night, in more than 200 languages (US).

If someone with dementia is missing

  1. STEP 115 minSearch close by firstCheck the house, garden, car and the places the person often walks to. Don’t spend longer than about 15 minutes.
  2. STEP 2911Then call for helpTell the operator the person has dementia and is a vulnerable adult. Police treat this as urgent.
  3. STEP 3PhotoHave details readyA recent photo, what they were wearing, medical conditions and places they used to live or work.

Based on Alzheimer’s Association guidance on wandering. Outside the US, call your local emergency number.